Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment
- PMID: 29626579
- PMCID: PMC6087675
- DOI: 10.1016/j.fct.2018.04.007
Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment
Abstract
Due to the extensive use of botanical dietary supplements by consumers in the United States, there is a need for appropriate research and data to support safety assessments. Complexity and variability, both natural and introduced, of botanical dietary supplements make research on these products difficult. Botanical dietary supplements are regulated by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the 1994 Dietary Supplement Health and Education Act (DSHEA). They are regulated as a category of food, which differs from the regulation of pharmaceutical products. Both manufacturers and the FDA are faced with the challenge of determining the best approaches for evaluating and monitoring the safety of botanical products. High quality botanicals research requires accurate identification and characterization of the material being studied. Inconsistent results in efficacy studies of botanical dietary supplements have led to efforts to improve the rigor and reproducibility of research in the field. Addressing the challenges associated with botanical dietary supplement safety is a global effort requiring coordination between numerous stakeholders, including researchers, suppliers, manufacturers, and regulators, all of whom play a role in ensuring that high quality products are available on the market.
Figures
Similar articles
-
Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs).Drug Test Anal. 2017 Mar;9(3):500-517. doi: 10.1002/dta.1980. Epub 2016 Jun 3. Drug Test Anal. 2017. PMID: 27259162 Review.
-
Pharmacopeial Standards for the Quality Control of Botanical Dietary Supplements in the United States.J Diet Suppl. 2023;20(3):485-504. doi: 10.1080/19390211.2021.1990171. Epub 2021 Oct 26. J Diet Suppl. 2023. PMID: 34699287
-
FDA regulation of dietary supplements and requirements regarding adverse event reporting.Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23. Clin Pharmacol Ther. 2010. PMID: 20032973
-
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.Int J Mol Sci. 2016 Mar 3;17(3):331. doi: 10.3390/ijms17030331. Int J Mol Sci. 2016. PMID: 26950122 Free PMC article. Review.
-
Chemical and biological characterization and clinical evaluation of botanical dietary supplements: a phase I red clover extract as a model.Curr Med Chem. 2004 Jun;11(11):1361-74. doi: 10.2174/0929867043365134. Curr Med Chem. 2004. PMID: 15180571 Review.
Cited by
-
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol (Polygonum cuspidatum), Luteolin, and Fisetin (Rhus succedanea).Int J Environ Res Public Health. 2021 Mar 3;18(5):2483. doi: 10.3390/ijerph18052483. Int J Environ Res Public Health. 2021. PMID: 33802381 Free PMC article. Clinical Trial.
-
Non-targeted chemical analysis of consumer botanical products labeled as blue cohosh (Caulophyllum thalictroides), goldenseal (Hydrastis canadensis), or yohimbe bark (Pausinystalia yohimbe) by NMR and MS.Anal Bioanal Chem. 2024 Jan;416(1):175-189. doi: 10.1007/s00216-023-05004-y. Epub 2023 Nov 1. Anal Bioanal Chem. 2024. PMID: 37910202 Free PMC article.
-
Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review.J Pharm Policy Pract. 2022 Sep 5;15(1):55. doi: 10.1186/s40545-022-00447-7. J Pharm Policy Pract. 2022. PMID: 36064655 Free PMC article.
-
Combined Exposures and Mixtures Research: An Enduring NIEHS Priority.Environ Health Perspect. 2024 Jul;132(7):75001. doi: 10.1289/EHP14340. Epub 2024 Jul 5. Environ Health Perspect. 2024. PMID: 38968090 Free PMC article.
-
Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials.Cancers (Basel). 2023 Jan 23;15(3):701. doi: 10.3390/cancers15030701. Cancers (Basel). 2023. PMID: 36765659 Free PMC article. Review.
References
-
- Abdel-Rahman A, Anyangwe N, Carlacci L, Casper S, Danam RP, Enongene E, Erives G, Fabricant D, Gudi R, Hilmas CJ, Hines F, Howard P, Levy D, Lin Y, Moore RJ, Pfeiler E, Thurmond TS, Turujman S, Walker NJ. The Safety and Regulation of Natural Products Used as Foods and Food Ingredients. Toxicol Sci. 2011;123:333–348. - PubMed
-
- Al-Amier H, Nasr KA, Lueck L, Gardner ZE, Craker LE. Phytochemical Variation in Black Cohosh Populations. In: Khan IA, editor. Proceedings of the IVth International Conference on Quality and Safety Issues Related to Botanicals: University, MS, USA, August 15 - 18, 2005. ISHS; Leuvin, Belgium: 2006. pp. 95–100.
-
- Azwanida NN. A Review on the Extraction Methods Use in Medicinal Plants, Principle, Strength and Limitation. Medicinal & Aromatic Plants. 2015;4:196–202.
-
- Barnes PM, Bloom B, Nahin RL. National Health Statistics Report. 12. National Center for Health Statistics; Hyattsville, MD: 2008. Complementary and alternative medicine use among adults and children: United States, 2007. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical